TRANSGENE (EPA:TNG) | WebDisclosure

PRESS RELEASE

published on 11/06/2025 at 08:30, 6 months 12 days ago

Transgene to Showcase Potential of Proprietary VacDesignR® Computational Tool to Optimize Individualized Therapeutic Cancer Vaccines
Transgene to present VacDesignR® tool at ESMO-AI 2025 for optimized cancer vaccine design. Tool enhances virus efficiency and yield for individualized therapies

Cancer Vaccines Computational Tool Transgene VacDesignR ESMO-AI 2025
BRIEF

published on 11/04/2025 at 17:55, 6 months 13 days ago

Transgene presents its progress and financial situation as of Q3 2025

Funding Immunotherapy Transgene TG4050 SITC 2025
BRIEF

published on 11/04/2025 at 17:55, 6 months 13 days ago

Transgene présente ses avancées et sa situation financière au T3 2025

Financement Immunothérapie Transgene TG4050 SITC 2025
PRESS RELEASE

published on 11/04/2025 at 17:50, 6 months 13 days ago

Transgene Provides Business and Financial Update for Q3 2025
Transgene provides business and financial update for Q3 2025, including immunogenicity data of INTV TG4050 in Phase I study on HNSCC. Company focuses on cancer immunotherapies

Financial Update Transgene INTV TG4050 Cancer Immunotherapies HNSCC
PRESS RELEASE

published on 11/04/2025 at 17:50, 6 months 13 days ago

Transgene fait le point sur ses activités et sa situation financière au troisième trimestre 2025
Transgene fait le point sur ses activités et sa situation financière au troisième trimestre 2025, notamment sur les avancées de son vaccin thérapeutique TG4050 contre le cancer de la tête et du cou

Cancer Situation Financière Transgene TG4050 Vaccin Thérapeutique
BRIEF

published on 10/20/2025 at 08:35, 6 months 29 days ago

Le BT-001 de Transgene et BioInvent présente une activité antitumorale prometteuse

Immunothérapie Contre Le Cancer Transgene Virus Oncolytique BT-001 Activité Antitumorale
BRIEF

published on 10/20/2025 at 08:35, 6 months 29 days ago

Transgene and BioInvent's BT-001 Shows Promising Antitumor Activity

Cancer Immunotherapy Transgene Oncolytic Virus BT-001 Antitumoral Activity
PRESS RELEASE

published on 10/20/2025 at 08:30, 6 months 29 days ago

Transgene and BioInvent’s Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors
Transgene and BioInvent's BT-001 oncolytic virus in combination with pembrolizumab shows positive antitumoral activity in refractory tumors. Exciting clinical data presented at ESMO 2025

Transgene Oncolytic Virus BioInvent BT-001 Pembrolizumab
BRIEF

published on 06/13/2025 at 08:35, 11 months 5 days ago

Transgene s'engage auprès des principales plateformes de l'industrie biotechnologique

Immunothérapie Traitement Du Cancer Transgene Données Cliniques Réunions Biotech
BRIEF

published on 06/13/2025 at 08:35, 11 months 5 days ago

Transgene Engages with Key Biotech Industry Platforms

Cancer Treatment Clinical Data Immunotherapy Transgene Biotech Meetings

Published on 05/18/2026 at 08:01, 4 hours 14 minutes ago

Result of Fundraise
Published on 05/17/2026 at 15:20, 20 hours 55 minutes ago

China XLX Announces 2026 Q1 Results
Published on 05/16/2026 at 01:15, 2 days 11 hours ago

Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 01:00, 2 days 11 hours ago

Arctic Fox Adopts Semi-Annual Reporting
Published on 05/16/2026 at 00:00, 2 days 12 hours ago

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate

View all ACCESSWIRE

Published on 05/18/2026 at 12:05, 9 minutes ago

ICEX's Audiovisual From Spain premieres three new short films at Cannes as part of its 'Where Talent Ignites' campaign
Published on 05/18/2026 at 12:05, 9 minutes ago

Ford Charges Ahead in Europe: Seven New Models and Smart Tech to Keep Vans on Road and Businesses Earning
Published on 05/18/2026 at 12:00, 15 minutes ago

PAL Next AG: Annual General Meeting Supports Strategic Realignment with Company Renaming and Election of New Supervisory Board
Published on 05/18/2026 at 11:45, 29 minutes ago

PWO AG has reappointed Carlo Lazzarini as member of the Executive Board and its Chairman for another 5 years
Published on 05/18/2026 at 11:36, 38 minutes ago

POS-Transaction in Own Shares

View all EQS

Published on 05/18/2026 at 11:06, 1 hour 9 minutes ago

GUILLEMOT CORPORATION: Weekly report share buyback From May 11th to May 15th 2026
Published on 05/18/2026 at 11:06, 1 hour 9 minutes ago

GUILLEMOT CORPORATION : Déclaration hebdomadaire des transactions sur actions propres du 11 mai 2026 au 15 mai 2026
Published on 05/18/2026 at 08:30, 3 hours 45 minutes ago

Thales appoints Jérémie Papin Senior Executive Vice-President, Finance and Information Systems
Published on 05/18/2026 at 08:30, 3 hours 45 minutes ago

Thales nomme Jérémie Papin Directeur général, Finance et Systèmes d’Information
Published on 05/15/2026 at 15:08, 2 days 21 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026

View all LES ECHOS COMFI WIRE

News